Outsourcing

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Articles

CMOs Plan for Capacity Expansions

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

Market forces may limit the success of CMOs.

Gauging the CMO Biosimilar Opportunity

There are significant differences between small molecules and biologics fill/finish capacity.

Fill/Finish Capacity Use for Biologics

Outsourcing is taking on a greater role in the biopharmaceutical manufacturing industry.

Year in Review: Trends in Biopharma Manufacturing Outsourcing

European CDMOs want into the US market, but entry options are limited.

Outside Looking In

The trend of exits from the CMO industry looks to be gaining momentum.

CMO Industry Thins Out

Annual study shows geographic proximity not a factor in CMO selection.

Targeting Different Off-Shore Destinations

As payers refuse to cover new drugs, CMOs take a hit.

Health Systems Raise the Bar on Reimbursing New Drugs

With budgets growing, clients see CMOs' costs as less crucial.

Outsourcing No Longer Just for Cost-Cutting

The CMO industry's value proposition is limiting its market penetration.

Outsourcing Outlook